Miristoleato de Cetilo

Volver al artículo.

Referencias para el artículo

  1. Diehl HW, May EL. Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. J Pharm Sci 1994;83:296-9.
  2. Diehl HW. Method for the treatment of osteoarthritis. U.S. Patent #5,569,676.
  3. Diehl HW. Method of treating rheumatoid arthritis. U.S. Patent #4,113,881.
  4. Diehl HW. Cetyl myristoleate. U.S. Patent #4,049,824.
  5. Siemandi H. The effect of cis-9-cetyl myristoleate (CMO) and adjunctive therapy on arthritis and auto-immune disease: a randomized trial. Townsend Letter for Doctors and Patients 1997;(Aug/Sept):58-63.